Top accelerator startups

14,448 startups · 29 programs

Relevium Medical

Active · Platform injectable gel based therapeutic for osteoarthritis

8signal of 100 · rising 2
  • team of 5Team size · YC's directory+4
  • went through YCProgram · this site+4

A sum of public facts, not a judgement and not investment advice.

Competitors

Adjacent

Also from S22

All of S22

About Relevium Medical

Relevium Medical is developing an injectable gel for knee osteoarthritis. Approximately half the population will be diagnosed with this pain and progressive disease. Right now, patients have to undergo not only repeat injections to control their pain, but also have to take strong oral medications. Because the disease is progressive and only gets worse over time, many patients end up on highly addictive, high-dose opioids. To date, we have secured $3.7 million in non dilutive funding and completed preclinical testing. We demonstrated that our drug is safe, selectively blocks nerves that transmit pain, and provides pain relief that lasts four times as long. Insurance currently pays $770 per six-monthly treatment for knee osteoarthritis. With 5 million patients in the US, this represents a $7.7 Bn market opportunity. This platform biotherapeutic can also be used to treat other joints affects by osteoarthritis such as the hip and ankle, where the same problems exist in treatment care.

YC batch
S22 · Summer 2022
Status, per YC
Active
Category
Other
Team size
5
Location
Galway, County Galway, Ireland
Checked
7h ago

YC tags: Medical Devices, Healthcare, Therapeutics, Drug discovery

Relevium Medical in S22: 233 companies, 54% AI

Relevium Medical: questions

Which YC batch was Relevium Medical in?

Relevium Medical was in Y Combinator's Summer 2022 batch (S22).

Is Relevium Medical still active?

Y Combinator lists Relevium Medical as active.

Where is Relevium Medical based?

Relevium Medical lists Galway, County Galway, Ireland as its location on YC's directory.